These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35853821)

  • 41. LINC00839/miR-144-3p/WTAP (WT1 Associated protein) axis is involved in regulating hepatocellular carcinoma progression.
    Zhou X; Chang Y; Zhu L; Shen C; Qian J; Chang R
    Bioengineered; 2021 Dec; 12(2):10849-10861. PubMed ID: 34634995
    [TBL] [Abstract][Full Text] [Related]  

  • 42. lncRNA-SNHG15 accelerates the development of hepatocellular carcinoma by targeting miR-490-3p/ histone deacetylase 2 axis.
    Dai W; Dai JL; Tang MH; Ye MS; Fang S
    World J Gastroenterol; 2019 Oct; 25(38):5789-5799. PubMed ID: 31636472
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C.
    Tao J; Liu Z; Wang Y; Wang L; Yao B; Li Q; Wang C; Tu K; Liu Q
    Biomed Pharmacother; 2017 Sep; 93():420-428. PubMed ID: 28666208
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MiR-29c-3p/C1QTNF6 Restrains the Angiogenesis and Cell Proliferation, Migration and Invasion in Head and Neck Squamous Cell Carcinoma.
    Huang F; Qi H
    Mol Biotechnol; 2023 Jun; 65(6):913-921. PubMed ID: 36348139
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
    Fei X; Zhang P; Pan Y; Liu Y
    Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of microRNA-141-3p in the progression and metastasis of hepatocellular carcinoma cell.
    Hou X; Yang L; Jiang X; Liu Z; Li X; Xie S; Li G; Liu J
    Int J Biol Macromol; 2019 May; 128():331-339. PubMed ID: 30695725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential of C1QTNF1-AS1 regulation in human hepatocellular carcinoma.
    Han W; Yu G; Meng X; Hong H; Zheng L; Wu X; Zhang D; Yan B; Ma Y; Li X; Wang Q
    Mol Cell Biochem; 2019 Oct; 460(1-2):37-51. PubMed ID: 31222560
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma.
    Wang W; Lin H; Zhou L; Zhu Q; Gao S; Xie H; Liu Z; Xu Z; Wei J; Huang X; Zheng S
    Eur J Surg Oncol; 2014 Nov; 40(11):1586-94. PubMed ID: 24290372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miR-34c-3p inhibits cell proliferation, migration and invasion of hepatocellular carcinoma by targeting MARCKS.
    Song J; Wang Q; Luo Y; Yuan P; Tang C; Hui Y; Wang Z
    Int J Clin Exp Pathol; 2015; 8(10):12728-37. PubMed ID: 26722462
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
    Liu L; Yang X; Li NF; Lin L; Luo H
    Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
    [No Abstract]   [Full Text] [Related]  

  • 52. MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner.
    Huang Z; Wen J; Yu J; Liao J; Liu S; Cai N; Liang H; Chen X; Ding Z; Zhang B
    J Exp Clin Cancer Res; 2020 Aug; 39(1):150. PubMed ID: 32746934
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-155-3p promotes hepatocellular carcinoma formation by suppressing FBXW7 expression.
    Tang B; Lei B; Qi G; Liang X; Tang F; Yuan S; Wang Z; Yu S; He S
    J Exp Clin Cancer Res; 2016 Jun; 35(1):93. PubMed ID: 27306418
    [TBL] [Abstract][Full Text] [Related]  

  • 54. C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3.
    Li H; Zhang B; Ding M; Lu S; Zhou H; Sun D; Wu G; Gan X
    Hepatol Int; 2019 May; 13(3):277-292. PubMed ID: 31069760
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Upregulation of microRNA-140-3p inhibits epithelial-mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN.
    Zhang QY; Men CJ; Ding XW
    J Cell Biochem; 2019 Sep; 120(9):14885-14898. PubMed ID: 31044454
    [TBL] [Abstract][Full Text] [Related]  

  • 56. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
    He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X
    Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of miR-541-3p/TMPRSS4 in the metastasis and EMT of hepatocellular carcinoma.
    Xia YH; Ren L; Li JZ; Gao F
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10721-10728. PubMed ID: 31858539
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MiR-652-3p promotes malignancy and metastasis of cancer cells via inhibiting TNRC6A in hepatocellular carcinoma.
    Chen W; Ru J; Wu T; Man D; Wu J; Wu L; Sun Y; Yu H; Li M; Zhang G; Zhu X; Tong R; Xiao H; Li Y; Yang B
    Biochem Biophys Res Commun; 2023 Jan; 640():1-11. PubMed ID: 36495604
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells.
    Liu Y; Li Y; Wang R; Qin S; Liu J; Su F; Yang Y; Zhao F; Wang Z; Wu Q
    J Exp Clin Cancer Res; 2016 Jan; 35():19. PubMed ID: 26817584
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overexpression of circ_0021093 circular RNA forecasts an unfavorable prognosis and facilitates cell progression by targeting the miR-766-3p/MTA3 pathway in hepatocellular carcinoma.
    Liu L; Qi X; Gui Y; Huo H; Yang X; Yang L
    Gene; 2019 Sep; 714():143992. PubMed ID: 31330234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.